Eventide Asset Management, LLC Voyager Therapeutics, Inc. Transaction History

Eventide Asset Management, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2019 May 15, 2019	SELL	$8.0 - $19.66 $3.49 Million - $8.57 Million	-436,000 Closed	0 $0
Q4 2018 Feb 14, 2019	SELL	$8.59 - $18.05 $2.3 Million - $4.83 Million	-267,425 Reduced 38.02%	436,000 $4.1 Million
Q4 2017 Feb 14, 2018	BUY	$12.26 - $25.88 $1.74 Million - $3.67 Million	142,000 Added 25.29%	703,425 $11.7 Million
Q3 2017 Nov 14, 2017	BUY	$8.37 - $20.59 $4.7 Million - $11.6 Million	561,425	561,425 $11.6 Million

130

34.7M

39.7K

34.6K

Ticker VYGR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 38,647,600
Market Cap $245M
Description
Voyager Therapeutics, Inc., a gene therapy company, focuses on the development of treatments and next-generation platform technologies. The company's lead clinical candidate is the VY-AADC, which is in open-label Phase 1 clinical trial for the treatment of Parkinson's disease. Its preclinical programs comprise VY-SOD102 for the treatment of amyo...

Get notified when there are updates to the investment portfolio of Eventide Asset Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Eventide Asset Management, LLC with notifications on news.